Skip to content

Drug interactions

Octreotide + Vandetanib

Severity: Major

Octreotide and Vandetanib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Vandetanib carries a boxed warning for QT prolongation, torsades de pointes and sudden death. Octreotide may add to this through bradycardia and conduction effects, and the combination is discouraged.

What this interaction means in plain words

Octreotide and Vandetanib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Octreotide belongs to Endocrine; Vandetanib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic QT prolongation.

What to do

Avoid the combination if possible. If both are needed, monitor ECG and electrolytes frequently and keep potassium, magnesium and calcium normal.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Octreotide and Vandetanib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Octreotide with Vandetanib?

MediHelp rates the interaction as major. Octreotide and Vandetanib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Vandetanib carries a boxed warning for QT prolongation, torsades de pointes and sudden death. Octreotide may add to this through bradycardia and conduction effects, and the combination is discouraged.

How serious is the interaction between Octreotide and Vandetanib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible. If both are needed, monitor ECG and electrolytes frequently and keep potassium, magnesium and calcium normal.

What other medicines interact with Octreotide?

MediHelp also lists interactions of Octreotide with, for example, Adagrasib, Amisulpride, Arsenic trioxide. The full list is on the Octreotide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in